Research Foundation: Brochure 23

Lila Prounis –
was the first woman elected to the all-male Greek Orthodox Archdiocesan Council and has been its United Nations Representative since 1979. From 1991-2000, she was the President of the Women’s National Republican Club and is currently its President Emeritus.Maria RazumichZec –
is the General Manager of The Peninsula Chicago, recently named the Top Hotel in the U.S. by Zagat. She serves on the boards of several organizations including The Waterbor Burn and Cancer Foundation and The Nic Zec Foundation for Lupus.Dr. Paul Russo –
is a urologist and an Associate Attending Surgeon for Cancer and Allied Diseases at Memorial Sloan Kettering. He is also an Associate Professor of Urology at Cornell University and a fellow at the American College of Surgeons. Dr. Russo received his M.D. from the College of Physicians and Surgeons at Columbia University.

Richard Salem –
is the founder of the law firm of Salem, Saxon, P.A. located in Tampa, Florida. He recently formed Enable America!, a political action committee dedicated to reducing the unemployment rate among people with disabilities. Mr. Salem received a Juris Doctorate from Duke Law School.

Richard Shortway –
served as a 1st Lieutenant with the US Air Force in WW II and flew thirty-one missions over Germany. After the war, he started at Conde Nast Publications and became Publisher of Vogue and eventually, Vice President in charge of Vogue and Vanity Fair magazines.

How You Can HelpYour contributions to the Michael Stern Parkinson’s Research Foundation will directly support the pioneering research of Nobel Prize winner Paul Greengard, Ph.D. and the team of scientists at the Stern facility at The Rockefeller University, who are working every day to find solutions to Parkinson’s. Donations of any size will advance our mission of finding a cure.These are just a few of the ways your contribution can help:

* Identify chemical compounds that can be developed into new treatments for Parkinson’s.

* Make current therapies more effective by tracing the pathways of dopamine signaling in the brain so that new ways can be discovered for increasing the effectiveness of dwindling supplies of dopamine in the brains of people with Parkinson’s.

* Advance preclinical research of potential new therapies in animal models of Parkinson’s disease, an early step in new drug development.

* Start clinical trials of promising new therapies developed in our laboratory. Simply put, your donation can help us cure Parkinson’s – and there is every reason to believe that we can cure Parkinson’s in years, not decades. Please help us help the people and families who suffer from this devastating disease.